GoodRx Bolsters Data Protection with HITRUST i1 Certification
Generado por agente de IAClyde Morgan
martes, 18 de febrero de 2025, 9:12 am ET1 min de lectura
GDRX--
GoodRx, a leading medication savings platform in the U.S., has recently earned the HITRUST i1 Certification for information security, further solidifying its commitment to data protection and cybersecurity. This certification, which covers AWS data centers in California, Ohio, Oregon, and Virginia, validates GoodRx's adherence to specific security standards and controls against current and emerging threats. The HITRUST i1 Certification helps organizations address cybersecurity challenges and remain cyber resilient over time.
The HITRUST i1 Certification requires GoodRx to implement and maintain a set of curated controls to protect against current and emerging threats. These controls are assessed by third-party auditors on an annual basis, ensuring GoodRx's ongoing commitment to data security and risk management. The certification covers AWS data centers in California, Ohio, Oregon, and Virginia, demonstrating GoodRx's adherence to regulatory standards and strengthening trust among consumers, healthcare providers, and industry partners.
GoodRx's Chief Technology Officer, Nitin Shingate, expressed the company's commitment to data protection and cybersecurity: "HITRUST i1 Certification is an important validation of the security and compliance measures we prioritize at GoodRx. Protecting data is fundamental to how we operate, and this certification provides an additional proof point of our commitment to cybersecurity and data protection."
The annual third-party audit process for HITRUST i1 Certification ensures GoodRx's ongoing commitment to data security and risk management by subjecting the company's drug savings platform to regular, independent assessments. This process helps validate the effectiveness of GoodRx's security controls, identify and address potential vulnerabilities, build and maintain trust with consumers, healthcare providers, and industry partners, and ensure continuous improvement in data protection efforts.
GoodRx's HITRUST i1 Certification is further evidence of the company's dedication to best practices for information risk management and cybersecurity. By achieving this milestone, GoodRx reinforces its leadership in healthcare data protection and gains a competitive edge in delivering reliable savings solutions. Jeremy Huval, Chief Innovation Officer at HITRUST, stated, "GoodRx’s HITRUST i1 Certification is further evidence that they are committed to best practices for information risk management and cybersecurity."
In conclusion, GoodRx's HITRUST i1 Certification demonstrates the company's unwavering commitment to data protection and cybersecurity. By implementing and maintaining robust security controls and undergoing annual third-party audits, GoodRx ensures the safety and privacy of its users' sensitive information. This certification further strengthens GoodRx's reputation and trust among consumers, healthcare providers, and industry partners, solidifying its position as a leader in healthcare data protection.

GoodRx, a leading medication savings platform in the U.S., has recently earned the HITRUST i1 Certification for information security, further solidifying its commitment to data protection and cybersecurity. This certification, which covers AWS data centers in California, Ohio, Oregon, and Virginia, validates GoodRx's adherence to specific security standards and controls against current and emerging threats. The HITRUST i1 Certification helps organizations address cybersecurity challenges and remain cyber resilient over time.
The HITRUST i1 Certification requires GoodRx to implement and maintain a set of curated controls to protect against current and emerging threats. These controls are assessed by third-party auditors on an annual basis, ensuring GoodRx's ongoing commitment to data security and risk management. The certification covers AWS data centers in California, Ohio, Oregon, and Virginia, demonstrating GoodRx's adherence to regulatory standards and strengthening trust among consumers, healthcare providers, and industry partners.
GoodRx's Chief Technology Officer, Nitin Shingate, expressed the company's commitment to data protection and cybersecurity: "HITRUST i1 Certification is an important validation of the security and compliance measures we prioritize at GoodRx. Protecting data is fundamental to how we operate, and this certification provides an additional proof point of our commitment to cybersecurity and data protection."
The annual third-party audit process for HITRUST i1 Certification ensures GoodRx's ongoing commitment to data security and risk management by subjecting the company's drug savings platform to regular, independent assessments. This process helps validate the effectiveness of GoodRx's security controls, identify and address potential vulnerabilities, build and maintain trust with consumers, healthcare providers, and industry partners, and ensure continuous improvement in data protection efforts.
GoodRx's HITRUST i1 Certification is further evidence of the company's dedication to best practices for information risk management and cybersecurity. By achieving this milestone, GoodRx reinforces its leadership in healthcare data protection and gains a competitive edge in delivering reliable savings solutions. Jeremy Huval, Chief Innovation Officer at HITRUST, stated, "GoodRx’s HITRUST i1 Certification is further evidence that they are committed to best practices for information risk management and cybersecurity."
In conclusion, GoodRx's HITRUST i1 Certification demonstrates the company's unwavering commitment to data protection and cybersecurity. By implementing and maintaining robust security controls and undergoing annual third-party audits, GoodRx ensures the safety and privacy of its users' sensitive information. This certification further strengthens GoodRx's reputation and trust among consumers, healthcare providers, and industry partners, solidifying its position as a leader in healthcare data protection.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios